PRTODAY / NewswireToday Free press release distribution service network

More news: Health/Surgery
Written by / Agency / Source: RevitalVision, LLC

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Vogue Magazine Feature Kansas Start-up Company Revitalvision in October 2009 Edition - Revitalvision unveiled as the world’s only proven non-surgical therapy to improve vision
Vogue Magazine Feature Kansas Start-up Company Revitalvision in October 2009 Edition

 

NewswireToday - /newswire/ - Lawrence, KS, United States, 2009/09/29 - Revitalvision unveiled as the world’s only proven non-surgical therapy to improve vision.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

More than 10 million Vogue readers were introduced to a Kansas-based company, RevitalVision, LLC, in a two-page feature in the October 2009 magazine. RevitalVision is the world’s only clinically and scientifically proven*, non-surgical therapy to improve vision. It increases the communication between your eyes and your brain to help you see better without surgery, drugs or glasses.

RevitalVision represents a new category in vision improvement -- a non-invasive technology that enhances eyesight neurologically. This computer-based, neural therapy is clinically and scientifically proven to improve the vision outcomes for post-cataract, post-refractive (LASIK) and presbyopia (need for reading glasses) patients.

Acclaimed Vogue health writer and former LASIK surgery patient Ginny Graves recently began experiencing a decline in vision resulting from presbyopia and was recommended RevitalVision by an eye surgeon. Like the thousands of RevitalVision clinical trial patients, Graves had success with the vision improvement program and subsequently no longer required reading glasses.

According to Grave’s article, “Headlights were less glary. Newsprint was crisper. When I sat down with a book before bed, I no longer had to hold the book at arm’s length to decipher words. And, when I went to my doctor for my final post-training exam, I could read the smallest letters on the eye chart: EDFCZP. I had gained a whole line on the eye chart! I’ve never been so happy to see anything in my life.”

“It was an honor to be validated by one of the top health writers in the country,” said Dennis Depenbusch, Chief Executive Officer of RevitalVision. “We are overwhelmed by the amount of interest the Vogue feature has created for RevitalVision, furthering our mission to simply help people see better, naturally.”

Based on science developed by Nobel Prize winner Dennis Gabor and originally developed in Israel in 1999, RevitalVision, formerly known as NeuroVision Inc., relocated to Singapore in 2004. Furthermore, RevitalVision underwent 10 years of development, including clinical trials, totaling more than $30 million of investment.

In 2009, three prominent ophthalmic surgeons, recognized as “Top 50 Influential Ophthalmologists in World” by Cataract and Refractive Surgery Today, led the purchase and the launch of U.S.-based RevitalVision. In addition to purchasing RevitalVision, each of these founders completed clinical trials and assisted in product development. Founding Ophthalmologists include: Dr. Daniel S. Durrie, MD, Overland Park, Kan.; Dr. John D. Hunkeler, MD, Overland Park, Kan.; and Dr. Richard L. Lindstrom, MD, Minneapolis, Minn.

On average, RevitalVision’s clinical trial patients’ vision improved by more than two lines on an eye chart, as well as improved contrast sensitivity by at least 100% after completion of the program. Additional benefits include:

- Ability to read smaller print on a newspaper, menu, or computer screen;
- Better vision at night - especially while driving;
- Reducing or eliminating the need for reading glasses.

Patients complete twenty 20-minute individual sessions and typically report improvement in as few as 10 sessions. This program is monitored online and allows users to complete the program in the comfort of their home, on their own time. It is tailored to an individual’s visual condition and paced according to their ability.

“RevitalVision will become an integral part of the way we enhance the visual outcome for our patients,” said Hunkeler. “After conducting the clinical trials, it was obvious RevitalVision was a product we could not afford to pass up. Our patients adapted and really improved their quality of vision, so we strongly encourage participation in the program.”

The program is professionally monitored and offers a 100 percent money-back guarantee. For more information and to purchase RevitalVision, please visit RevitalVison.com/.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: RevitalVision, LLC

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Vogue Magazine Feature Kansas Start-up Company Revitalvision in October 2009 Edition

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Dennis Depenbusch - RevitalVision.com 
785-215-0932 info[.]revitalvision.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any RevitalVision, LLC securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From RevitalVision, LLC / Company Profile


Read Health/Surgery Most Recent Related Newswires:

Persistence Market Research Publishes Microtome Cryostat Equipment Market Opportunities and Forecasts, 2017-2025
North America to Account for 4.3% CAGR in Global Hip Replacement Market Reports Persistence Market Research
HPMC Capsules Market to Register 10.9% CAGR During 2017-2025 Finds Persistence Market Research
Persistence Market Research Publishes Blood Thinner Market Opportunities and Forecasts 2017-2025
Occupational Medicine Market Estimated to Expand At A Robust CAGR Over 2025 Notes PMR
Persistence Market Research Publishes Traditional Chinese Medicine Market Forecast Over 2017-2025
Inferior Vena Cava Filters Market to Register A Strong Growth by 2025 Notes Persistence Market Research
Plasma Component Separator Market Set to Surge Significantly During 2017-2025 Says PMR
Persistence Market Research Releases Fertility Enhancing Treatment Market Snapshot by 2017-2025
Disposable Diabetes Devices Market Expected to Generate Huge Profits by 2025 Finds Reports Persistence Market Research
Cardiac Biomarkers Market Expected to Generate Huge Profits by 2017-2025 Reports PMR
Stone Management System Market Foreseen to Grow Exponentially Over 2017-2025 Finds PMR
Global Hemoglobinopathy Market Worth US$ 788M by 2024 According to Persistence Market Research
Dentsu Announces its Corporate Venture Capital Fund Dentsu Ventures Investment in Grail
Xenex Receives Top Honors from Frost & Sullivan for LightStrike™ - the Only Pulsed Xenon UV Disinfection System in the Healthcare Market

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit RightITnow Ltd

Visit  MagLar, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)